{"name":"Centre for Addiction and Mental Health","slug":"centre-for-addiction-and-mental-health","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":8,"colorKey":"oncology","drugs":[{"name":"Bupropion Augmentation","genericName":"Bupropion Augmentation","slug":"bupropion-augmentation","indication":"Other","status":"marketed"},{"name":"Apo-Oxycodone CR®","genericName":"Apo-Oxycodone CR®","slug":"apo-oxycodone-cr","indication":"Other","status":"marketed"},{"name":"Dexedrine","genericName":"Dexedrine","slug":"dexedrine","indication":"Other","status":"marketed"},{"name":"Dietary Supplement","genericName":"Dietary Supplement","slug":"dietary-supplement","indication":"Support digestive health","status":"marketed"},{"name":"Motherwell","genericName":"Motherwell","slug":"motherwell","indication":"Other","status":"phase_2"},{"name":"Nicotine Replacement Therapy Agent","genericName":"Nicotine Replacement Therapy Agent","slug":"nicotine-replacement-therapy-agent","indication":"Other","status":"marketed"},{"name":"Placebo plus clinical management","genericName":"Placebo plus clinical management","slug":"placebo-plus-clinical-management","indication":"Substance use disorders (used as control/comparator in clinical trials)","status":"marketed"},{"name":"main antipsychotic medication and placebo","genericName":"main antipsychotic medication and placebo","slug":"main-antipsychotic-medication-and-placebo","indication":"Other","status":"phase_1"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":6,"colorKey":"immunology","drugs":[{"name":"Switch to bupropion","genericName":"Switch to bupropion","slug":"switch-to-bupropion","indication":"Major depressive disorder","status":"marketed"},{"name":"Aripiprazole Augmentation","genericName":"Aripiprazole Augmentation","slug":"aripiprazole-augmentation","indication":"Augmentation therapy for major depressive disorder in patients with inadequate response to antidepressants","status":"marketed"},{"name":"Corticotropin-Releasing Hormone","genericName":"Corticotropin-Releasing Hormone","slug":"corticotropin-releasing-hormone","indication":"Treatment of major depressive disorder","status":"phase_2"},{"name":"Lithium Augmentation","genericName":"Lithium Augmentation","slug":"lithium-augmentation","indication":"Major depressive disorder with inadequate response to antidepressant monotherapy","status":"marketed"},{"name":"Nabilone Oral Capsule","genericName":"Nabilone Oral Capsule","slug":"nabilone-oral-capsule","indication":"Chemotherapy-induced nausea and vomiting (CINV)","status":"marketed"},{"name":"Switch to nortriptyline","genericName":"Switch to nortriptyline","slug":"switch-to-nortriptyline","indication":"Major depressive disorder","status":"marketed"}]},{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Tobacco","genericName":"Tobacco","slug":"tobacco","indication":"Relief of occasional eye overexertion","status":"marketed"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"OxyNEO®","genericName":"OxyNEO®","slug":"oxyneo","indication":"Moderate to severe pain requiring around-the-clock opioid therapy","status":"marketed"}]}],"pipeline":[{"name":"Bupropion Augmentation","genericName":"Bupropion Augmentation","slug":"bupropion-augmentation","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Switch to bupropion","genericName":"Switch to bupropion","slug":"switch-to-bupropion","phase":"marketed","mechanism":"Bupropion is an atypical antidepressant that inhibits the reuptake of norepinephrine and dopamine, increasing their availability in the brain.","indications":["Major depressive disorder","Seasonal affective disorder","Smoking cessation (as Zyban/Wellbutrin SR)","ADHD (off-label use)"],"catalyst":""},{"name":"Tobacco","genericName":"Tobacco","slug":"tobacco","phase":"marketed","mechanism":"Small molecule","indications":["Relief of occasional eye overexertion"],"catalyst":""},{"name":"Apo-Oxycodone CR®","genericName":"Apo-Oxycodone CR®","slug":"apo-oxycodone-cr","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Aripiprazole Augmentation","genericName":"Aripiprazole Augmentation","slug":"aripiprazole-augmentation","phase":"marketed","mechanism":"Aripiprazole augmentation enhances the efficacy of antidepressants by acting as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, improving mood regulation in treatment-resistant depression.","indications":["Augmentation therapy for major depressive disorder in patients with inadequate response to antidepressants","Treatment-resistant depression"],"catalyst":""},{"name":"Corticotropin-Releasing Hormone","genericName":"Corticotropin-Releasing Hormone","slug":"corticotropin-releasing-hormone","phase":"phase_2","mechanism":"Corticotropin-Releasing Hormone stimulates the release of adrenocorticotropic hormone (ACTH) from the pituitary gland, which in turn increases cortisol production.","indications":["Treatment of major depressive disorder"],"catalyst":""},{"name":"Dexedrine","genericName":"Dexedrine","slug":"dexedrine","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Dietary Supplement","genericName":"Dietary Supplement","slug":"dietary-supplement","phase":"marketed","mechanism":"Small molecule","indications":["Support digestive health","Maintain normal intestinal flora"],"catalyst":""},{"name":"Lithium Augmentation","genericName":"Lithium Augmentation","slug":"lithium-augmentation","phase":"marketed","mechanism":"Lithium augmentation enhances the efficacy of antidepressant medications by potentiating serotonergic and noradrenergic neurotransmission in the brain.","indications":["Major depressive disorder with inadequate response to antidepressant monotherapy","Treatment-resistant depression"],"catalyst":""},{"name":"Motherwell","genericName":"Motherwell","slug":"motherwell","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Nabilone Oral Capsule","genericName":"Nabilone Oral Capsule","slug":"nabilone-oral-capsule","phase":"marketed","mechanism":"Nabilone is a synthetic cannabinoid that mimics THC by binding to cannabinoid receptors in the central nervous system to produce antiemetic and analgesic effects.","indications":["Chemotherapy-induced nausea and vomiting (CINV)","Chronic pain","Multiple sclerosis-related spasticity"],"catalyst":""},{"name":"Nicotine Replacement Therapy Agent","genericName":"Nicotine Replacement Therapy Agent","slug":"nicotine-replacement-therapy-agent","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"OxyNEO®","genericName":"OxyNEO®","slug":"oxyneo","phase":"marketed","mechanism":"OxyNEO is an extended-release formulation of oxycodone designed to deter abuse by resisting crushing, dissolving, and extraction while maintaining analgesic efficacy.","indications":["Moderate to severe pain requiring around-the-clock opioid therapy"],"catalyst":""},{"name":"Placebo plus clinical management","genericName":"Placebo plus clinical management","slug":"placebo-plus-clinical-management","phase":"marketed","mechanism":"Placebo plus clinical management provides psychological benefit through expectation effects combined with structured clinical support and therapeutic interaction.","indications":["Substance use disorders (used as control/comparator in clinical trials)"],"catalyst":""},{"name":"Switch to nortriptyline","genericName":"Switch to nortriptyline","slug":"switch-to-nortriptyline","phase":"marketed","mechanism":"Nortriptyline is a tricyclic antidepressant that inhibits the reuptake of norepinephrine and serotonin at neuronal synapses, increasing their availability in the central nervous system.","indications":["Major depressive disorder","Chronic pain conditions","Neuropathic pain","Migraine prophylaxis"],"catalyst":""},{"name":"main antipsychotic medication and placebo","genericName":"main antipsychotic medication and placebo","slug":"main-antipsychotic-medication-and-placebo","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNbnd3ZUItWlRrdERPY1ZidFlfOHZTbDNFNTFuM0FPMTQ5WXgwMVl1OFRRa3ljNkFneDFTbXpWdDdYVG1WYXNKT3lWQ0lJZl9WQjFESjNWaUZ6R0hDN3VyYTNlZm54OFUxYklhZzdZMzBoUVdDVnVQMTdldlRjNkJIM1ZLb0Q0bFEyM0ZGRnVwYTc3c3UwYzlkTWZ4QkRZSjNHanRr?oc=5","date":"2025-12-23","type":"pipeline","source":"addictioncenter.com","summary":"How Purdue Pharma and the Sackler Family Perpetrated the Opioid Crisis - addictioncenter.com","headline":"How Purdue Pharma and the Sackler Family Perpetrated the Opioid Crisis","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-06-04","type":"pipeline","source":"India Today","summary":"Indian-origin pharma tycoon arrested in US for healthcare fraud - India Today","headline":"Indian-origin pharma tycoon arrested in US for healthcare fraud","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNQW50OEk0MGtRVm9XR3FMclMtY3k1dmNfQnFkZnBvaHozT2o3VWhyc3dldTVMUXo5cjR5eWlQMXIwZFZYSGJ3aVA1XzliX1FxVGIxa21HUTBSb2Mtc0VwbWlwWTROMk9USVhodUlXeFdqUVZVcWdQOExaLVV1Zm5HRkszRG16bkt4MWRtZWxLWG94bkQ2cGhQdXRpa00?oc=5","date":"2025-01-29","type":"pipeline","source":"NPR","summary":"RFK Jr. says he'll fix the overdose crisis. Critics say his plan is risky - NPR","headline":"RFK Jr. says he'll fix the overdose crisis. Critics say his plan is risky","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNU0l6SW55a2J0WGxfU3ZOX0RaTkVKUmRVM0ZHRzZxVmpQSTh1amRZcEhoSkhOdFlIck5RUC1FRWFMY1BBaF9sbHBOWEk2WGxGeGZEbEtkWUpwUUctdVNGR0JkOXhQQ2t1MFE0dHptcFFXRVVGejI1Q0toWnVDWmVwSUZUNGxLUzlwamMyNzV3aVh0TzRPTnBrS3J1WGk1VnNBZmJMZENzTS0xMEtfVWVKbFNuc1loa2ZGcF9WTjVnRzRFSzdCejUwdEtuT01Edw?oc=5","date":"2025-01-28","type":"pipeline","source":"The Centre for Addiction and Mental Health | CAMH","summary":"New CAMH-Developed Drug Shows Promise in Reversing Memory Loss for Early Alzheimer's Patients - The Centre for Addiction and Mental Health | CAMH","headline":"New CAMH-Developed Drug Shows Promise in Reversing Memory Loss for Early Alzheimer's Patients - The Centre for Addiction","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQc3V5ZjBiLWJBU1lrVFBBOERfSHRmWXp6RWlVb2lkNTdnWGJsQmdjTzJ0NzhucUx0aGp0V2hSVDdUOGpINkpfVFdWdGhLbjNQcjFWaGRRNWtHQURSUzZlMXdselkxMkUwLXMwMTRPSlJTMEpvVDlFeWVabUE2a0hGaS01bEs?oc=5","date":"2024-10-10","type":"pipeline","source":"C&EN","summary":"Can diabetes drugs like Ozempic tackle the mental health crisis? - C&EN","headline":"Can diabetes drugs like Ozempic tackle the mental health crisis? - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNcFNZcTA3Y3V1aWRVOUhRaTlpdzdISEZ5bm9oVmZidUlZM1p0ajZTcWxFaW50ek1Mb21UcWl3MVFlcHd6MU45eG1BMk9MaXdqQ1JoZ3k5azBNY0t3VHd1R0J1TzNUdGc1dDJpaFJ5ampWVU5Ec3BNT3ZGU0tWUUNzamtMd0s3dFlTZWpoMXdzemNCcEc0eDZrMXViVjc1NUhpTmt2eTRGS1pDV0VKQmlTODBWT21fNE1lYlNZTENlRFBqeUVRb3paRWdFSXdoclE3bmlOY2FDalhYOGNnZlRRcW9DaVF0LTI1RGtrcg?oc=5","date":"2024-07-11","type":"pipeline","source":"Petrie-Flom Center","summary":"Unseen Scars: The Devastating Impact of Corruption on Mental Health Systems in Low and Middle-Income Countries - Petrie-Flom Center","headline":"Unseen Scars: The Devastating Impact of Corruption on Mental Health Systems in Low and Middle-Income Countries - Petrie","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQajhkdWM0UFQ5R1pFMVUxSUdyaWJuRk13cWpwNno0RVdVQ2p0X1F5dVoyUUhnRHpYTFBXd2ZRTnJtcjh2NWhlRVZLYmJyUEZfWHB5Tmxkb0NrWG0tTTY4QlZybVRCSkVpZXR5ekNlZ1lBVVA3REhnckYzUm1pd1NRTUk1SGxaaVhhd1loWDV3SGQ1MW9ibTVlNGJkdWx5d2o3Ul9EcVRFTmI?oc=5","date":"2024-05-02","type":"pipeline","source":"pharmaceutical-journal.com","summary":"Bridging the mental health gap: the role of pharmacists - pharmaceutical-journal.com","headline":"Bridging the mental health gap: the role of pharmacists - pharmaceutical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQckNpUmg2UXF4cmo4QnphZzhuVXNBMUdScjhVSDdGcS04dTY0ay1JN3Q5b014c0FYT1R0LUJXNW9xWGxxb1pJanFRNmgzS0s3UkU4aUhaY0FUb1NOdHJUZGxpUl9sTU5IdmRqamxfcWtCNmxmVFpkMkdDNzk3VGZqem94czRqd3pHR094aFB2WGx4ZDhoWUE?oc=5","date":"2024-01-11","type":"pipeline","source":"Frontiers","summary":"Pills and the damage done: the opioid epidemic as man-made crisis - Frontiers","headline":"Pills and the damage done: the opioid epidemic as man-made crisis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPUVhIZTZBU3F1UFlEaURmTFlJMTlOY1pNLVVvR3ByaUlpTnptM1d3T1N6VkhlNmtFcURVdWI4VzFIMFRWa19IdmdUMEZNZXVscDh5UmJfRmkxa3VUZ2kxVlRnUWVIZjh4SXJQVlluRE56T21lTVUwNVZ5M204dWlMQklRUmdvQ2FXOE5aQmxReGY3VGFIeDdsTEVFdEkxUHVlN1doRFdGdkRrRW96N0w2dTJCUVNmYXdoXzVMSnNzaVlWTWZmTmFqMQ?oc=5","date":"2023-11-06","type":"pipeline","source":"TechTarget","summary":"Psychiatrists Prescribe or Recommend Ozempic, Other Weight Loss Drugs - TechTarget","headline":"Psychiatrists Prescribe or Recommend Ozempic, Other Weight Loss Drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE1yVHVUdlREQUl4M0V1OUtZanY4V3JobDNpZFR6Uk1qUUFETDBMUTNqOEF4RjBCMmM4eE1HQ1VNS1JwbFBsWXRFUUFYRi1FeHBfa1hlV19wS1JSRzRGVTNfSWE2V1ZtVW1FQ1dNNzc2cEhrUQ?oc=5","date":"2023-01-25","type":"pipeline","source":"Psychiatry.org","summary":"Opioid Use Disorder - Psychiatry.org","headline":"Opioid Use Disorder","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNdkh6NmZIOFhGaU9JbU14UFBYaDc4aEtHNlFwbFVxc2pnSXBrRUtGVmVzUUQ1YUYxVUZ3X1ZwRlE1SnJIV3RJRlFfYno5bFRKT2tRRVBCR1pIY2N3eU9PS2dETVNSSmVNSExZb0FLam9ZRE11dnFHUXFBQzZuNzhCNmJZY3p3RFJ3aVpCWWNR?oc=5","date":"2022-10-06","type":"pipeline","source":"UW-Milwaukee","summary":"Cook recognized for scientific leadership in biohealth research - UW-Milwaukee","headline":"Cook recognized for scientific leadership in biohealth research - UW","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxNcXBKc1NXMzZTaURxUzJzWWJ1aHJyamJrWE91LW9xZnF3b2xCNk1fYThBVWdYcjVHd09XNmpDczZJZEtnbnZUUGJzRHZOOHA5alpUZVhjRHAzLXBZcU1GMnUxZGNWVERCUTI1c3RTdzV1VWhVSGp4aUNTY2VCOEJHdnBJd0xLQ2lnZF9qV3B4b0lrMWcyVXRISV9zb3NPSlk0SGdHZWJLT1d0YTR3R2pYTlI5THl4ZWhWS3kxb3JRS1hET2c3NUhNVW9BcFVFdm0wcjFkLXhBU05TRDhzX2hkNUI2emEzQlZh?oc=5","date":"2014-03-15","type":"pipeline","source":"France 24","summary":"Beyond Business - Money and Mental Health: Did Big Pharma write 'The Psychiatrist's Bible'? - France 24","headline":"Beyond Business - Money and Mental Health: Did Big Pharma write 'The Psychiatrist's Bible'? - France 24","sentiment":"neutral"}],"patents":[],"drugCount":16,"phaseCounts":{"marketed":13,"phase_2":2,"phase_1":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}